Nowadays it is also commercially available as HER2sense, labeled with a red fluorophore emitting at 661 nm (Perkin Elmer [180]), allowing to in vivo study HER-2 expression mainly in mammary tumors. This evidence concerns the gene ERBB2 and breast cancer.